Zdrowie i gospodarka · 14/08/2014

FDA Announces Draft Guidance for De Novo Classification Process

The FDA is releasing a draft guidance document outlining its proposals for the de novo classification process, which allows for the submission of novel devices without a premarket notification, following the passage of the Food and Drug Administration Safety and Innovation Act in 2012.